Compare IVVD & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVVD | CPSS |
|---|---|---|
| Founded | 2020 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.6M | 202.0M |
| IPO Year | 2021 | 2010 |
| Metric | IVVD | CPSS |
|---|---|---|
| Price | $0.46 | $8.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 22.6K |
| Earning Date | 11-16-2026 | 10-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.02 | 1.27 |
| EPS | N/A | ★ 0.80 |
| Revenue | $53,426,000.00 | ★ $434,470,000.00 |
| Revenue This Year | $12.92 | $142.25 |
| Revenue Next Year | $44.18 | N/A |
| P/E Ratio | ★ N/A | $11.24 |
| Revenue Growth | ★ 110.47 | 10.41 |
| 52 Week Low | $0.49 | $7.46 |
| 52 Week High | $3.01 | $10.49 |
| Indicator | IVVD | CPSS |
|---|---|---|
| Relative Strength Index (RSI) | 30.94 | 40.79 |
| Support Level | N/A | $7.60 |
| Resistance Level | $0.66 | $9.78 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 5.08 | 7.51 |
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.